Parthiban Chokkalingam

Dr. Parthiban Chokkalingam

School of Pharmacy & Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, Minnesota, USA
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Composites Part B: Engineering
Verified
Journal Article
Closed access
MSMelvin S. Samuel
Melvin S. Samuel
VSVasudevan Subramaniyan
Vasudevan Subramaniyan
JBJayanta Bhattacharya
Jayanta Bhattacharya
Parthiban ChokkalingamParthiban Chokkalingam
Parthiban Chokkalingam
SCSantanu Chand
Santanu Chand
NSN.D. Pradeep Singh
N.D. Pradeep Singh

1 December 2018 in Ultrasonics Sonochemistry
Verified
Journal Article
Closed access
MSMelvin S. Samuel
Melvin S. Samuel
JBJayanta Bhattacharya
Jayanta Bhattacharya
Parthiban ChokkalingamParthiban Chokkalingam
Parthiban Chokkalingam
GVGayathri Viswanathan
Gayathri Viswanathan
NSN.D. Pradeep Singh
N.D. Pradeep Singh

Verified
Journal Article
Open access
PDF file
BDBhaskar Das
Bhaskar Das
Parthiban ChokkalingamParthiban Chokkalingam
Parthiban Chokkalingam
PMPavithra Masilamani
Pavithra Masilamani
Srushti ShuklaSrushti Shukla
Srushti Shukla
SDSasmita Das
Sasmita Das
Drug delivery systems, which use components at the nanoscale level as diagnostic tools or to release therapeutic drugs to particular target areas in a regulated manner, are a fast-evolving field of science. The active pharmaceutical substance can be released via the drug delivery system to produce the desired therapeutic effect. The poor bioavailability and irregular plasma drug levels of conventional drug delivery systems (tablets, capsules, syrups, etc.) prevent them from achieving sustained delivery. The entire therapy process may be ineffective without a reliable delivery system. To achieve optimal safety and effectiveness, the drug must also be administered at a precision-controlled rate and the targeted spot. The issues with traditional drug delivery are overcome by the development of stimuli-responsive controlled drug release. Over the past decades, regulated drug delivery has evolved considerably, progressing from large- and nanoscale to smart-controlled drug delivery for several diseases. The current review provides an updated overview of recent developments in the field of stimuli-responsive boron-based materials in drug delivery for various diseases. Boron-containing compounds such as boron nitride, boronic acid, and boron dipyrromethene have been developed as a moving field of research in drug delivery. Due to their ability to achieve precise control over drug release through the response to particular stimuli (pH, light, glutathione, glucose or temperature), stimuli-responsive nanoscale drug delivery systems are attracting a lot of attention. The potential of developing their capabilities to a wide range of nanoscale systems, such as nanoparticles, nanosheets/nanospheres, nanotubes, nanocarriers, microneedles, nanocapsules, hydrogel, nanoassembly, etc., is also addressed and examined. This review also provides overall design principles to include stimuli-responsive boron nanomaterial-based drug delivery systems, which might inspire new concepts and applications.

1 March 2018 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
MPM. Pavithra
M. Pavithra
SMS. Muruganand
S. Muruganand
Parthiban ChokkalingamParthiban Chokkalingam
Parthiban Chokkalingam

1 August 2015 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
Parthiban ChokkalingamParthiban Chokkalingam
Parthiban Chokkalingam
KEKuppanagounder P. Elango
Kuppanagounder P. Elango

1 August 2016 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
Parthiban ChokkalingamParthiban Chokkalingam
Parthiban Chokkalingam
SCSamuele Ciattini
Samuele Ciattini
LCLaura Chelazzi
Laura Chelazzi
KEKuppanagounder P. Elango
Kuppanagounder P. Elango